Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome

Contraception

Volumn 82, Issue 3, 2010, Pages 276-280

  De Leo, Vincenzo ^a   Di Sabatino, Alessandra ^a   Musacchio, Maria C ^a   Morgante, Giuseppe ^a   Scolaro, Valeria ^a   Cianci, Antonio ^b   Petraglia, Felice ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

Hyperandrogenism; Oral contraceptives; PCOS; SHBG

Indexed keywords

ANDROSTERONE; CHLORMADINONE ACETATE; CHLORMADINONE ACETATE PLUS ETHINYLESTRADIOL; DESOGESTREL; DESOGESTREL PLUS ETHINYLESTRADIOL; DROSPIRENONE; DROSPIRENONE PLUS ETHINYLESTRADIOL; ETHINYLESTRADIOL; ETHINYLESTRADIOL PLUS GESTODENE; GESTODENE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADOLESCENT; ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; DRUG EFFECT; FEMALE; HORMONE BLOOD LEVEL; HUMAN; HYPERANDROGENISM; OVARY POLYCYSTIC DISEASE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; TESTOSTERONE BLOOD LEVEL;

ADOLESCENT; ADULT; ANDROSTENEDIONE; ANDROSTENES; CHLORMADINONE ACETATE; CONTRACEPTIVES, ORAL, COMBINED; DEHYDROEPIANDROSTERONE SULFATE; DESOGESTREL; ETHINYL ESTRADIOL; FEMALE; HUMANS; HYPERANDROGENISM; NORPREGNENES; POLYCYSTIC OVARY SYNDROME; PROGESTERONE CONGENERS; SEX HORMONE-BINDING GLOBULIN; STATISTICS, NONPARAMETRIC; TESTOSTERONE; YOUNG ADULT;

EID: 77955582567     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2010.04.002     Document Type: Article

References (16)

1. De Leo V., La Marca A., and Petraglia F. Insulin-lowering agents in the management of polycystic ovary syndrome Endocr Rev 24 2003 633 667
2. Raudrant D., and Rabe T. Progestogens with antiandrogenic properties Drugs 63 2003 463 492
3. Wiegratz I., Jung-Hoffmann C., and Kuhl H. Effect of two oral contraceptives containing ethinylestradiol and gestodene or norgestimate upon androgen parameters and serum binding proteins Contraception 51 1995 341 346
4. De Leo V., Morgante G., and Piomboni P. Evaluation of effects of an oral contraceptive containing ethinylestradiol combined with drospirenone on adrenal steroidogenesis in hyperandrogenic women with polycystic ovary syndrome Fertil Steril 88 1 2007 113 117
5. Van der Spuy Z.M., and le Roux P.A. Cyproterone acetate for hirsutism Cochrane Database Syst Rev 2003 CD001125
6. Guido M., Romualdi D., and Giuliani M. Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: a clinical, endocrinological, metabolic pilot study J Clin Endocrinol Metab 89 2004 2817 2823
7. Palep-Singh M., Mook K., and Barth J. An observational study of Yasmin in the management of women with polycystic ovary syndrome J Fam Plann Reprod Health Care 30 2004 163 165
8. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum Reprod 19 2004 41 47
9. Wiegratz I., Kutschera E., and Lee J.H. Effect of four different oral contraceptives on various sex hormones and serum-binding globulins Contraception 67 2003 25 32
10. Blume-Peytavi U., and Hahn S. Medical treatment of hirsutism Dermatol Ther 2008 329 339
11. Vrbíková J., and Cibula D. Combined oral contraceptives in the treatment of polycystic ovary syndrome Hum Reprod Update 11 2005 277 291
12. Van der Vange N., Blankenstein M.A., and Kloosterboer H.J. Effects of seven low-dose combined oral contraceptives on sex hormone binding globulin, corticosteroid binding globulin, total and free testosterone Contraception 41 1990 345 352
13. Falsetti L., Gambera A., and Platto C. Management of hirsutism Am J Clin Dermatol 1 2000 89 99
14. Falsetti L., Gambera A., and Tisi G.C. Efficacy of the combination ethinyl oestradiol and cyproterone acetate on the endocrine, clinical and ultrasonographic profile in polycystic ovarian syndrome Hum Reprod 16 2001 36 42
15. Falsetti L. Sex hormone-binding globulin during treatment with various combined oral contraceptives Gynecol Obstet 2 1988 131 136
16. Falsetti L., Galbigliani E., and Comberti E. Effetti di 8 contraccettivi orali su SHBG, CBG, e testosterone libero Perspectives Gynecol Obstet 6 1989 65 70